Clinical Trial Update: Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of capecitabine and docetaxel for metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED